Itamar Medical (Israel) Probability of Target Price Finishing Over Current Price

    ITMR -- Israel Stock  

    ILS 136.40  2.20  1.59%

    Itamar Medical probability of target price tool provides mechanism to make assumptions about upside and downside potential of Itamar Medical Ltd performance during a given time horizon utilizing its historical volatility. Please specify Itamar Medical time horizon, a valid symbol (red box) and a target price (blue box) you would like Itamar Medical odds to be computed. Please also check Risk vs Return Analysis.
    Horizon     30 Days    Login   to change
    Symbol:
    Refresh Odds

    Itamar Medical Target Price Odds to finish over

    Current PriceHorizonTarget PriceOdds to move above current price in 30 days
     136.40 30 days 136.40  ABOUT 5.72%
    Based on normal probability distribution, the odds of Itamar Medical to move above current price in 30 days from now is about 5.72% (This Itamar Medical Ltd probability density function shows the probability of Itamar Medical Stock to fall within a particular range of prices over 30 days) .
    Assuming 30 trading days horizon, Itamar Medical has beta of 0.1665 . This indicates as returns on market go up, Itamar Medical average returns are expected to increase less than the benchmark. However during bear market, the loss on holding Itamar Medical Ltd will be expected to be much smaller as well. Additionally Itamar Medical Ltd has an alpha of 0.395 implying that it can potentially generate 0.395% excess return over DOW after adjusting for the inherited market risk (beta).
     Itamar Medical Price Density 
     
          
    Current Price   Target Price   
    α
    Alpha over DOW
    =0.39
    β
    Beta against DOW=0.17
    σ
    Overall volatility
    =5.66
    Ir
    Information ratio =0.29

    Itamar Medical Alerts

    Itamar Medical Alerts and Suggestions

    Itamar Medical is not yet fully synchronised with the market data
    Itamar Medical has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations
    The company reported revenue of 21.83 M. Net Loss for the year was (4.63 M) with profit before overhead, payroll, taxes, and interest of 15.7 M.
    ITAMAR MEDICAL has accumulated about 4.26 M in cash with (4.58 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02.
    Please also check Risk vs Return Analysis. Please also try Idea Breakdown module to analyze constituents of all macroaxis ideas. macroaxis investment ideas are predefined, sector-focused investing themes.
    Search macroaxis.com